(3-carboxamidino-2-oxo-2H-chromen-7-yl)-4-guanidinobenzoates are novel blockers of pH-sensitive ion channels
Sukach VA, Buta AZ, Maksymiuk OP, Koval's'kyĭ DB, Vovk MV, Kryshtal' OO
- Institute of Organic Chemistry of NAS of Ukraine, Kyiv, Ukraine
- O.O.Bogomoletz Institute of Physiology, National Academy of Sciences of Ukraine, Kyiv, Ukraine
- International Center Molecular Physiology, National Academy of Sciences of Ukraine, Kyiv, Ukraine
DOI: https://doi.org/10.15407/fz57.06.031
Abstract
Ischemic stroke is one of the most severe brain pathologies that is extremely difficult to treat. Recently it has been found that acidosis accompanying cerebral ischemia induces activation of acid-sensing ion channel ASIC1a which results in its turn in the neuronal death. Here we present novel derivatives of 3-carboxamidinocoumarines that effectively inhibit ASIC1a and ASIC3 channels in concentration-dependent manner. The most active compound inhibits ASIC1a and ASIC3 channels with corresponding IC50 of 7.3 and 13.2 uM. Our data suggest that 3-carboxamidinocoumarines can be used as a scaffold for novel type of highly efficient anti-ischemic drugs.
Keywords:
3-амидино-7-гидроксикумарины,блокаторы рН-чувствительных ионных каналов, антиише-мические препараты.
References
- Mashkovsky M.D. Medicines. 15th ed., Revised, ed. and ext. M .: New Wave Publishing House. 2005. 1200 p.
- Escoubas P., Bernard C., Lambeau G., Lazdunski M., Darbon H. Recombinant production and solution structure of PcTx1, the specific peptide inhibitor of ASIC1a proton-gated cation channels . Protein Sci. 2003. 12. P. 1332-1343.
CrossRef
PubMed PubMedCentral
- Farinola N., Piller N. Pharmacogenomics: Its role in reestablishing coumarin as treatment for lymphedema . Lymphat. Res. and Biol. 2005. 3 (2). P. 81-86.
CrossRef
PubMed
- Korkushko A.O., Kryshtal O.A. Organic-cation-blocking of proton-induced sodium permeability in the membrane of rat trigeminal neurons . Neurophysiology. 1984. 16, N 4. P. 557-561.
- Krishtal O. The ASICs: Signaling molecules? Modulators? . Trends in Neurosci. 2003. 26, N 9. P. 477-483.
CrossRef
- Kuduk S.D., Di Marco C.N., Bodmer-Narkevitch V., Cook S.P., Cato M.J., Jovanovska A., Urban M.O., Leitl M., Sain N., Liang A., Spencer R.H., Kane S.A., Hartman G.D., Bilodeau M.T. Synthesis, structure activity relationship, and pharmacological profile of analogs of the ASIC-3 inhibitor A-317567 . ACS Chem. Neurosci. 2010. 1, N 1. P. 19-24.
CrossRef
PubMed PubMedCentral
- Link K.P. The Discovery of dicumarol and its sequels . Circulation. 1959. 19, N 1. P. 97-107.
CrossRef
PubMed
- Pignataro G., Simon R.P., Xiong Z. G. Prolonged activation of ASIC1a and the time window for neuroprotection in cerebral ischaemia . Brain 2007. 130. P.151-158.
CrossRef
PubMed
- Ugawa S., Ishida Y., Ueda T., Inoue K., Nagao M., Shimada S. Nafamostat mesilate reversibly blocks acid-sensing ion channel currents. . Biochem. Biophys. Res. Commun. 2007. 363. P. 203-208.
CrossRef
PubMed
- Xiong Z.-G., Pignataro G., Li M., Chang S.Y., Simon R.P. Acid-sensing ion channels (ASICs) as pharmaco-logical targets for neurodegenerative diseases . Curr. Opinion in Pharm. 2008. 8. N 1. P. 25-32.
CrossRef
PubMed PubMedCentral
- Xiong Z.-G., Zhu X.-M., Chu X.-P., Minami M., Hey J., Wemmie J.A., Price M., Welsh M.J., Simon R.P. Neuroprotection in ischemia: blocking calcium-permeable acid-sensing ion channels .
|